Umeno Katsumi, Hori Etsuro, Tsubota Masahito, Shojaku Hideo, Miwa Takaki, Nagashima Yoshinao, Yada Yukihiro, Suzuki Toshiyuki, Ono Taketoshi, Nishijo Hisao
System Emotional Science, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
Br J Clin Pharmacol. 2008 Feb;65(2):188-96. doi: 10.1111/j.1365-2125.2007.02992.x. Epub 2007 Oct 22.
Relationships between smell sensation and autonomic changes have been studied extensively. However, the possibility that odorants may also act on the lung and lower airway remains unknown.
The present results provide the first evidence that the lung and lower airway exert an inhibitory influence on the cardiovascular system in response to Cedrol (odorant) in the air under physiological conditions.
Previous studies reported that Cedrol (odorant) inhalation (CI) induced changes in autonomic balance and baroreceptor sensitivity (BRS) in both healthy subjects and anosmic patients. This suggests that Cedrol may act on the lower airway, and that the pulmonary system may exert an inhibitory influence on the cardiovascular system.
To test the above possibility, vaporized Cedrol (64.0 +/- 7.7 10(-9)m) or blank air was directly inhaled through the lower airway from a hole in the trachea, but not through the upper airway, using totally laryngectomized subjects. During the experiment, ECG, systolic (SBP) and diastolic (DBP) blood pressures were measured. Sympathetic and parasympathetic nervous activity was estimated by spectral analyses of variability in these parameters (heart rate variability (HRV), SBP variability (SBPV) and DBP variability (DBPV)). BRS was computed from transfer gain between SBP and the R-R interval of the ECG.
SBP and DBP significantly decreased during CI, although there were no significant differences in HR and respiratory rate. BRS significantly increased during CI. The low frequency components of SBPV and DBPV (indices for sympathetic activity) significantly decreased during CI, while high frequency components of HRV (an index for parasympathetic activity) significantly increased.
The present experiment using totally laryngectomized patients replicated the similar results in healthy subjects who inhaled Cedrol through the nose, suppression of sympathetic outflow and increase in parasympathetic outflow. These results demonstrated that Cedrol acts on the lower airway and pulmonary system, and suggest a new target for drug therapy of hypertension.
嗅觉与自主神经变化之间的关系已得到广泛研究。然而,气味剂是否也可能作用于肺部和下呼吸道仍不明确。
目前的结果首次证明,在生理条件下,肺部和下呼吸道会对空气中的雪松醇(气味剂)做出反应,对心血管系统产生抑制作用。
先前的研究报告称,吸入雪松醇(气味剂)(CI)会导致健康受试者和嗅觉缺失患者的自主神经平衡和压力感受器敏感性(BRS)发生变化。这表明雪松醇可能作用于下呼吸道,且肺部系统可能对心血管系统产生抑制作用。
为了验证上述可能性,使用全喉切除患者,通过气管上的一个孔直接经下呼吸道吸入汽化的雪松醇(64.0±7.7×10⁻⁹m)或空白空气,而非经上呼吸道吸入。实验过程中,测量心电图、收缩压(SBP)和舒张压(DBP)。通过对这些参数(心率变异性(HRV)、SBP变异性(SBPV)和DBP变异性(DBPV))的变异性进行频谱分析来估计交感神经和副交感神经活动。BRS由SBP与心电图R-R间期之间的传递增益计算得出。
吸入雪松醇期间,SBP和DBP显著下降,尽管心率和呼吸频率无显著差异。吸入雪松醇期间BRS显著增加。吸入雪松醇期间,SBPV和DBPV的低频成分(交感神经活动指标)显著下降,而HRV的高频成分(副交感神经活动指标)显著增加。
本实验使用全喉切除患者,重现了健康受试者经鼻吸入雪松醇后的类似结果,即交感神经输出受抑制,副交感神经输出增加。这些结果表明雪松醇作用于下呼吸道和肺部系统,并提示高血压药物治疗的新靶点。